Patient-reported toxic effects of hypofractionated versus conventional RT https://www.nature.com/articles/s41585-024-00883-x

Correction: In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis https://www.nature.com/articles/s41388-024-03031-2

Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers https://www.nature.com/articles/s41585-024-00869-9

Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort https://www.nature.com/articles/s41391-024-00830-2

New insight into combating drug-resistant prostate cancer New research sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that the development of drug resistance could be prevented by limiting the activity of coregulator proteins.
https://www.sciencedaily.com/r....eleases/2024/04/2404